Current US and EU secondary liability standards do not address all factors to trigger liability. This influences legislation and case law, setting an uncertain secondary liability outcome of IP infringement cases against Internet Intermediaries’. I suggest that tort law can tackle this problem.
Unlike other sectors, improvements in Genetic technology raise issues of morality. The new human gene editing technology CRISPR/CAS9 has raised many such concerns. Can the current patent system deal with these concerns or should morality be dealt with by the inventors themselves?
Do you have an ICD and live in the border region? In that case, it is possible that your cardiologist is located in a neighbouring country. According to EU law, EU citizens have the possibility to receive cross-border care. Nevertheless, it appears that this health care provision is not widely...
The need to guarantee the free flow of information in a Big Data economy forces us to re-think Intellectual Property Rights and find an appropriate balance between competition, innovation, privacy and incentives.
With or without the UK, the EU will try to find a way to implement the UPC as it has invested considerable time and efforts knowing the benefits it will bring; however, the fate of the Agreement could be decided on judicial grounds instead of political ones.
This post is co-written by Dr. Jill Robbie (Glasgow University) and Anna Berlee (MEPLI fellow). It is a cross-post from the University of Glasgow School of Law Blog.
